Cambrooke Therapeutics Announces Launch of New Family of Medical Foods for Inborn Errors of Metabolism

Business News
Print
AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of an advanced family of amino acid-based medical foods for the dietary management of several disorders of amino acid metabolism. These disorders include Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Isovalaric Acidemia (IVA), Homocystinurea (HCU) and Methylmalonic Acidemia (MMA)/Propionic Acidemia (PA). Ca

imageimage
image